MORE THAN HALF OF RA PATIENTS WITH A LIFETIME HISTORY OF MOOD DISORDERS WERE ANXIOUS AND DEPRESSED DURING THE COVID-19 PANDEMIC: RESULTS FROM THE CANADIAN EARLY COHORT (CATCH) STUDY

ANNALS OF THE RHEUMATIC DISEASES

BMJ PUBLISHING GROUP

1. Amgen
2. Pfizer Canada
3. AbbVie Corporation
4. Medexus
5. Sandoz Canada
6. Fresenius Kabi Canada
7. Organon Canada
8. Janssen Canada
9. UCB Canada
10. Bristol-Myers Squibb Canada
11. Hoffman La Roche Limited
12. Sanofi Genzyme
13. Eli Lilly Canada
14. Merck Canada
15. Gilead Sciences Canada